# Arch Pharmalabs Ltd., Thane, India – FDA Inspections

Source: https://www.keypedia.com/companies/arch-pharmalabs-ltd/2766781c-7a1a-4718-bb0e-04fa9616a574

> Inspection records and compliance data for Arch Pharmalabs Ltd. in Thane. 5 FDA inspections on record, 2 Form 483s, last inspected September 12, 2025.

---

## Details

- Name: Arch Pharmalabs Ltd.
- FEI Number: 3002808114
- Business Operations: API MANUFACTURE
- Address Line 1: Plot C21-22 & F40 Midc, Phase 2, Sagaon, Dombivli
- City: Thane
- Country Name: India
- Address: Plot C21-22 & F40 Midc, Phase 2, Sagaon, Dombivli, Thane, India
- Country: India

## Related Documents

- [483 - Arch Pharmalabs Ltd. - 2025-09-12](https://www.keypedia.com/records/483/arch-pharmalabs-ltd/29c5f104-fb22-4e8d-860f-39f3009ce95f) — source: FDA, date: September 12, 2025
- [FDA Inspection 1288012 - Arch Pharmalabs Ltd. - 2025-09-12](https://www.keypedia.com/records/fda_inspections/arch-pharmalabs-ltd/c506ae8d-354a-4fcf-be84-76708a491681) — source: FDA, date: September 12, 2025
- FDA Inspection 1288012 - Arch Pharmalabs Ltd. - 2025-09-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 12, 2025
- [FDA Inspection 1055379 - Arch Pharmalabs Ltd. - 2018-05-25](https://www.keypedia.com/records/fda_inspections/arch-pharmalabs-ltd/c8de2ea1-5985-4673-b55c-77318732ae87) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 25, 2018
- [FDA Inspection 956907 - Arch Pharmalabs Ltd. - 2016-01-29](https://www.keypedia.com/records/fda_inspections/arch-pharmalabs-ltd/72989440-44d8-4e08-b614-483180aa0804) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2016
- FDA Inspection 833403 - Arch Pharmalabs Ltd. - 2013-05-03 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2013
- FDA Inspection 662652 - Arch Pharmalabs Ltd. - 2009-12-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 5, 2009

## Related Companies

- [Natco Pharma Ltd. - Chemical Division](https://www.keypedia.com/companies/natco-pharma-ltd-chemical-division/3d56c2ac-4a7d-4f9f-8987-966d0ff5e5f1)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025)
- [Aarti Pharmalabs Limited](https://www.keypedia.com/companies/aarti-pharmalabs-limited/94a0adf3-5840-4cc1-9582-8eafd52d498e)
- [Jiangxi Synergy Pharmaceutical, Co., Ltd.](https://www.keypedia.com/companies/jiangxi-synergy-pharmaceutical-co-ltd/9602f29a-9a10-4201-966c-b89b6a2d3ae5)
- [Zhejiang Cheng Yi Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-cheng-yi-pharmaceutical-co-ltd/dabc68a0-9969-418a-9cd6-54e9987ed8df)
- [Zach System S.A.](https://www.keypedia.com/companies/zach-system-sa/c663917a-2b9d-4375-bc79-2cdd0e280002)
- [Wuhan Biocause Pharmaceutical Development Co., Ltd.](https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb)
- [Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)](https://www.keypedia.com/companies/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/13be9174-238f-43cf-bdf4-0c57cc0b0bc2)
- [Albemarle US, Inc.](https://www.keypedia.com/companies/albemarle-us-inc/336600a7-808b-4d7d-bfc0-7a9e728aa0aa)
- [Somerville Acquisitions, Inc.](https://www.keypedia.com/companies/somerville-acquisitions-inc/195f0557-96af-4562-98e7-9e03150b33cb)

## Related Officers

- [Consumer Safety Officer (Inspector)](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)